肝切除术与微波消融治疗巴塞罗那临床肝癌分期中消融理想候选者的肝细胞癌:倾向性评分匹配与逆概率加权分析
研究比较经皮微波消融与肝切除术治疗符合巴塞罗那临床肝癌分期消融理想候选者标准的肝细胞癌患者。2013年8月至2020年11月纳入483例患者,肝切除术在总体人群和BCLC-A亚组中无复发生存优于微波消融,总生存相似;BCLC-0患者两组结局等效。
要点
- 肝切除术在总体人群及BCLC-A亚组中无复发生存优于微波消融,总生存及并发症率相似。
- BCLC-0患者微波消融与肝切除术的总生存、无复发生存及并发症率等效。
- 多因素Cox回归显示肝切除术与更优无复发生存相关(总体HR=0.67,BCLC-A HR=0.74)。
核心结论
- 按BCLC分期的消融理想候选者可能并非微波消融的理想候选者。
- BCLC-0患者可能是微波消融的最佳人群。
研究设计与样本
- 研究纳入2013年8月至2020年11月间符合BCLC分期消融理想候选者标准的483例连续患者,初始接受微波消融(n=168)或肝切除术(n=315)。
- 患者进一步分为BCLC-0组(n=116)和BCLC-A组(n=367),在总体人群和亚组中于倾向性评分匹配及逆概率加权前后比较总生存、无复发生存和术后相关并发症率。
- 采用多因素Cox回归分析判断治疗方式是否为独立预后因素。
主要发现
- 在总体人群和BCLC-A亚组中,倾向性评分匹配及逆概率加权前后,肝切除术相比微波消融无复发生存更优,总生存和术后相关并发症率相似。
- 在BCLC-0患者中,倾向性评分匹配及逆概率加权前后,两组总生存、无复发生存和术后相关并发症率等效。
- 多因素Cox回归显示,肝切除术相比微波消融与更优无复发生存相关:总体人群p=0.003,HR=0.67,95%CI 0.51-0.87;BCLC-A疾病p=0.046,HR=0.74,95%CI 0.56-0.99;总生存无差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Liver resection (LRE) and microwave ablation (MWA) for hepatocellular carcinoma (HCC) have been widely compared. AIMS: To compare the therapeutic outcomes of percutaneous MWA and LRE for HCC in ideal candidates for ablation according to Barcelona Clinic Liver Cancer (BCLC) staging METHODS: Between August 2013 and November 2020, 483 consecutive patients meeting criteria for "ideal candidates for ablation" per the BCLC staging initially treated with MWA (n = 168) or LRE (n = 315) were included. Patients were further divided into BCLC-0 (n = 116) and BCLC-A (n = 367) groups. Overall survival (OS), recurrence-free survival (RFS) and post-procedure-related complication rates were compared before and after propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) in the overall population and subgroups. Multivariate Cox regression analysis was performed to determine whether the treatment modality was an independent prognostic factor. RESULTS: LRE had a better RFS and similar OS and post-procedure-related complication rates compared to MWA in the overall population and in the BCLC-A subgroup both before and after PSM and IPTW. However, the OS, RFS and post-procedure-related complication rates were equivalent between the two groups before and after PSM and IPTW in patients with BCLC-0 disease. The multivariate Cox regression analysis showed that LRE was associated with better RFS over MWA in overall population (p = 0.003; HR = 0.67; 95% CI: 0.51-0.87) and BCLC-A disease (p = 0.046; HR = 0.74; 95% CI: 0.56-0.99), while it did not differ in OS. CONCLUSION: An 'ideal candidate for ablation' according to the BCLC staging system may not be an ideal candidate for MWA. However, patients with BCLC-0 may be the optimal population for MWA.
引用
- Tong Y, Cai R, Li JX, et al. Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis. Aliment Pharmacol Ther. 2022. PMID: 36285593. doi:10.1111/apt.17263
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。